Brainsway Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Brainsway Ltd., a foreign private issuer, on December 22, 2025. The filing covers the month of December 2025 and is incorporated by reference into the Company's Registration Statements on Form S-8 and Form F-3.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial statement.
Material Changes and Corporate Developments
- Regulatory Expansion: The Company reported an expansion of adolescent depression coverage applicable to its Deep Transcranial Magnetic Stimulation (Deep TMS) technology.
- Exhibit Reference: Detailed information regarding this coverage expansion is contained in Exhibit 99.1.
Guidance, Outlook, and Risks
The filing text does not provide updated financial guidance, management commentary on future performance, specific risk factors, or details on contingencies beyond the announcement of the coverage expansion.
Investor Verification Checklist
- Verify the specific payers and geographic regions included in the new adolescent depression coverage for Deep TMS.
- Review Exhibit 99.1 for the full press release or official announcement details.
- Assess the potential impact of this coverage expansion on future revenue streams and market penetration.